Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
The article presents the current data of history of polycystic ovary syndrome (PCOS) study. It contains studies of genetic susceptibility of PCOS, PCOS symptoms and connection with development of anxiety and depressive disorders. The article covers ethnic differences in the phenotypic manifestations of PCOS. The papers describes the study of endocrine causes of infertility in Russian and Buryat women. Several theories of PCOS, including the theory of PCOS connection with intestinal bacterial flora disorders (“dysbiotic intestinal microbiota”) are being discussed. The article also provides an overview of various scientific research in this area and the data of the relationship of PCOS and the risk of cardiometa-bolic disorders, insulin resistance, metabolic syndrome, obesity and sleep apnea. It highlights modern aspects in the study of PCOS etiology – studies of adipose tissue as an endocrine organ. The article reflects study of PCOS relationship with the level of the gastrointestinal tract hormones: leptin, insulin, ghrelin, cholecystokinin, peptide YY. The effect of short-term low-dose hormonal contraceptives on appetite levels in PCOS is covered. The scientific articles on the severity of hypertension in menopausal women with PCOS history and the presence of overweight are reviewed. The scientific work determines molecular genetic markers of PCOS in the aspect of the influence of environmental factors on the expression of genes.
PCOS, Stein-Leventhal syndrome, infertility, oligomenorrhea, insulin resistance, hyperandrogenism, hirsutism, polycystic ovaries, intestinal microbiota
1. AliyevaEA, OvsyannikovaTV, PshenichnikovaTY(1991). Infertility caused by PCOS. [Besplodie, obuslovlen-noe sindromom polikistoznyih yaichnikov]. Аkusherstvo i ginekologiya, (6), 59-62.
2. AliyevaEA, PshenichnikovaTY, GasparovAS (1989). Pathophysiology of polycystic ovary syndrome [Pa-tofiziologiya sindroma polikistoznyih yaichnikov]. Аkusherstvo i ginekologiya, (4), 4-5.
3. NazarenkoTA, SotnikovaEI, DurinyanER (1996). The rules and algorisms for ovulation stimulation in infertility, caused by impaired function of the hypotha-lamic-pituitary axis [Printsipyi i shemyi stimulyatsii ovulyatsii pri besplodii, obuslovlennom narusheniyami funktsii gipotalamo-gipofizarnoy sistemyi]. Аkusherstvo i ginekologiya, (5), 46-50.
4. SerovVN, PrilepskayaVN, PshenichnikovaTY (1995). Practical guide to gynecologic endocrinology [Praktich-eskoe rukovodstvo po ginekologicheskoy endokrinologii], 440.
5. ShipkhineevaTI, SuturinaLV, DarzhaevZY, Tsyren-ovTB, RinchindorzhievaMP (2010). Characteristics of en-docrine infertility causes in Russian and Buryat according o the data from medical aid appealability [Kharakteristika prichin endokrinnogo besplodiya u russkikh i buryatok po dannym obrashchaemosti]. Bulleten’ Vostocno-Sibirskogo naucnogo centra, (6), 99-101
6. ShulunovSS, SheninVA, KolesnikovaLI, LabyginaAV, SuturinaLV, BolshakovaSE (2011). Role of polymorphic genes in polycystic ovary syndrome development [Rol’ polimorfnykh genov v razvitii sindroma polikistoznykh yaichnikov]. Sibirskiy Meditsinskiy Zhurnal, (7), 5-8
7. АhimaRS, FlierJS (2000).Adipose tissue as an endocrine organ.Trends Endocrinology Metabolism,(11), 327-332
8. ArusogluG, KoksalG, CinarN, TapanS, AksoyDY, YildizBO (2013). Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ova-ry syndrome: effect of low-dose oral contraceptive. The Journal of Clinical Endocrinology and Metabolism, (11), 82.
9. AzzizR, AdashiEY (2016). Stein and Leventhal: 80 years on. Obstetrics Gynecology,(2), 247.
10. BhattacharyaS, JhaA (2010). Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS). Fertility & Sterility, (94), 357.
11. CooperHE, SpellacyWN, PremKA, CohenWD(1968). Hereditary factors in Stein-Levental syndrome. Obstetrics Gynecology, (7), 371-387.
12. DeeksA, Gibson-Helm M, TeedeH (2010). Anxiety and depression in polycystic ovary syndrome: a compre-hensive investigation. Fertility & Sterility, (93), 242.
13. EltingMW, KorsenTJ, BezemerPD, SchoemakerJ(2001).Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population.Human Reproduction,(16), 556-560.
14. FauserBC, TarlatzisBC, RebarRW (2012). Con-sensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Spon-sored 3rd PCOS Consensus Workshop Group. Fertility & Sterility (97), 28-38
15. FosterGD, SandersMH, MillmanR, ZammitG, Bor-radaileKE, NewmanAB, WaddenTA, KelleyD, WingRR, SunyerFX, DarceyV, KunaST (2009).Obstructive sleep apnea among obese patients with type 2 diabetes.Diabe-tes Care, (32), 1017-1019.
16. HahnS, HaselhorstU, QuadbeckB, TanS, Kim-migR, MannK, JanssenOE (2006). Decreased soluble leptin receptor levels in women with polycystic ovary syndrome. Endocrinology(154), 287-294.
17. HlaKM, YoungT, FinnL, PeppardPE, Szk-lo-CoxeM, StubbsM (2008). Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. En-docrinology, (31), 795-800.
18. MаnssonM (2008). Women with polycystic ovary syndrome are often depressed or anxious-A case control study. Psychoneuroendocrinology, (33), 1132-1138.
19. MoranLJ, NoakesM, CliftonPM, WittertGA, LeRouxCW, GhateiMA, BloomSR, NormanRJ (2007). Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. The American Journal of Clinical Nutrition, 86(6), 1603-1610.
20. NobelsF, DewaillyD (1992). Puberty and poly-cystic ovarian syndrome: the insulin/insulin-like growth factor hypothesis. Fertility & Sterility, (4), 655-666.
21. OeiM, KazerR (1992). Variability of serum gonadotropin and dehydroepiandrosterone sulfate con-centrations in women with polycystic ovary syndrome. Iranian Journal of Reproductive Medicine, (12), 974-979.
22. PirwanyIR, FlemingR, SattarN, GreerIA, Wal-laceAM (2001).Circulating leptin concentrations and ovarian function in polycystic ovary syndrome.Endocri-nology,(145), 289-294.
23. PusalkarM, MeherjiP, GokralJ, SavardekarL, ChinnarajS, MaitraA (2010).Obesity and polycystic ova-ry syndrome: association with androgens, leptin and its genotypes.Gynecology & Endocrinology,(26), 874-882.
24. RandevaHS, ТаnBK, WeickertMO, LoisK,NestlerJE, SattarN, LehnertH (2012). Cardiometabolic aspects of the polycystic ovary syndrome. Review of En-docrinology, 33(5), 812-41.
25. SattarN, WannametheeG, SarwarN, ChernovaJ, LawlorDA, KellyA, WallaceAM, DaneshJ, WhincupPH (2009).Leptin and coronary heart disease: prospective study and systematic review. Journal of the American College of Cardiology, (153), 167-175.
26. ScottTKelley, Skarra DV,RiveraAJ, Thackray VG (2016). The gut microbiome is altered in a letro-zole-induced mouse model of polycystic ovary syn-drome, PLoS ONE, (1)5; 11(1). doi: 10.1371/journal.pone.0146509.
27. SomersVK, WhiteDP, AminR, AbrahamWT, CostaF, CulebrasA, DanielsS, FlorasJS, HuntCE, OlsonLJ, PickeringTG, RussellR, WooM, YoungT (2008). Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Ed-ucation Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. Journal of the American College of Cardiology, (52), 686-717.
28. SteinIF, LevinthalML (1935). Amenorrhea associated with bilateral polycystic ovaries, Obstetrics Gynecology, (29), 181-191
29. TasaliE, ChapototF, LeproultR, WhitmoreH,EhrmannDA (2011). Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome.The Journal of Clinical Endocrinology and Metabolism (96), 365-374.
30. ТasaliE, MokhlesiB, Van CauterE (2008).Ob-structive sleep apnea and type 2 diabetes: interacting epidemics.Chest Journal,(133), 496-506
31. TremellenK, PearceK(2012) Dysbiosis of Gut Microbiota (DOGMA) – a novel theory for the development of Polycystic Ovarian Syndrome. Medical Hypotheses, 79(1), 104. doi:10.1016/j.mehy.2012.04.016 [PubMed].
32. TsilchorozidouT, BatterhamRL, ConwayGS(2008). Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovar-ian syndrome (PCOS). Clinical Endocrinology, 69(6), 936-942
33. VgontzasAN, LegroRS, BixlerEO, GrayevA,KalesA, ChrousosGP (2001).Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.The Journal of Clinical Endocrinology and Metabolism, (86), 517-520.
34. VrbíkovaJ, CífkovaR, JirkovskaA, LanskaV, PlatilovaH, ZamrazilV, StarkaL (2003). Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.Human Reproduction,(18), 980-984.
35. YildizhanR, IlhanGA, YildizhanB, KolusariA,AdaliE, BugdayciG (2011). Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylargi-nine levels in obese and nonobese young women with polycystic ovary syndrome. Fertility & Sterility, (96), 246-250.
36. ZhaoL, GuoY, QiY, YangX, WenS, LiuY, TangL(2016). Association between Polycystic Ovary Syndrome andGutMicrobiota, PLoS ONE, 11(4), doi: 10.1371/journal.pone.0153196 [PubMed].
37. ZhaoY, QiaoJ (2013). Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids, (78), 755-760.
38. WeickertMO, HodgesP, TanBK, RandevaHS (2012). Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin. Minerva Endocrinologica, 37(1), 25-40
